Is preventive medicine responsible for the increasing prevalence of heart failure?

This publication has 13 references indexed in Scilit:

• The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
  Journal of Cardiac Failure, 1997
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
  The Lancet, 1997
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
  The Lancet, 1995
• Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction
  Journal of the American College of Cardiology, 1993
• Trends in hospitalization for heart failure in Scotland 1980-1990
  European Heart Journal, 1993
• Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
  New England Journal of Medicine, 1992
• Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.
  Heart, 1992
• Epidemiology and prevention of cardiac failure: Framingham Study insights
  European Heart Journal, 1987